(Q46466612)

22 December 2017

title

Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years (English)

1 reference

22 December 2017

0 references

6

1 reference

22 December 2017

Tomáš Kalinčík

10

1 reference

22 December 2017

Dana Horáková

12

1 reference

22 December 2017

Niels Bergsland

object named as

N Bergsland

2

0 references

author name string

R Zivadinov

1

1 reference

22 December 2017

O Dolezal

3

1 reference

22 December 2017

S Hussein

4

1 reference

22 December 2017

Z Seidl

5

1 reference

22 December 2017

M Vaneckova

7

1 reference

22 December 2017

J Krasensky

8

1 reference

22 December 2017

J A Potts

9

1 reference

22 December 2017

E Havrdová

11

1 reference

22 December 2017

publication date

11 April 2013

1 reference

22 December 2017

American Journal of Neuroradiology

published in

1 reference

22 December 2017

volume

34

1 reference

22 December 2017

issue

10

1 reference

22 December 2017

page(s)

1931-1939

1 reference

22 December 2017

Gray matter pathology in (chronic) MS: modern views on an early observation

cites work

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Advances in understanding gray matter pathology in multiple sclerosis: are we ready to redefine disease pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Gray matter involvement in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Gray matter atrophy in multiple sclerosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Gray matter imaging in multiple sclerosis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Meningeal and cortical grey matter pathology in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Grey matter pathology in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Individual voxel-based analysis of brain magnetization transfer maps shows great variability of gray matter injury in the first stage of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Cortical atrophy is relevant in multiple sclerosis at clinical onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Regional grey matter atrophy in clinically isolated syndromes at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Improved optimization for the robust and accurate linear registration and motion correction of brain images

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

A Bayesian model of shape and appearance for subcortical brain segmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Early predictors of non-response to interferon in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3503

21 January 2018

Identifiers

DOI

10.3174/AJNR.A3503

1 reference

22 December 2017

1 reference

22 December 2017